Hormone replacement therapy and endometrial carcinoma.

Hormone replacement therapy and endometrial carcinoma.

Bibliographic Details
Main Authors:	Doll, R, Kinlen, L, Skegg, D, Smith, P
Format:	Journal article
Language:	English
Published:	1977

Similar Items

INCIDENCE OF ENDOMETRIAL CARCINOMA
by: Doll, R, et al.
Published: (1976)

Endometrial cancer and hormone-replacement therapy in the Million Women Study.
by: Beral, V, et al.
Published: (2005)

Letter: Incidence of endometrical carcinoma.
by: Doll, R, et al.
Published: (1976)

Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition.
by: Allen, N, et al.
Published: (2010)

Hormone replacement therapy
by: Grant, C, et al.
Published: (1999)

Integrated genomic characterization of endometrial carcinoma
by: Park, Peter J., et al.
Published: (2014)

Interpretation of somatic POLE mutations in endometrial carcinoma
by: León-Castillo, A, et al.
Published: (2020)

Safety of hormone replacement therapy after mastectomy.
by: Mar, D, et al.
Published: (2002)

Hormone replacement therapy and ovarian cancer.
by: Beral, V, et al.
Published: (1991)

Future prospects for hormone replacement therapy.
by: Reeve, J
Published: (1992)

HORMONE REPLACEMENT THERAPY AND OVARIAN-CANCER
by: Beral, V, et al.
Published: (1991)

Ovarian cancer and hormone replacement therapy - Reply
by: Beral, V, et al.
Published: (2007)

Clinicopathological and molecular characterisation of ‘multiple-classifier’ endometrial carcinomas
by: León-Castillo, A, et al.
Published: (2020)

Early effects of hormone replacement therapy on bone.
by: Patel, S, et al.
Published: (1999)

Impact of hormone replacement therapy on breast cancer
by: Gathani, T, et al.
Published: (2010)

Hormone replacement therapy. Clinical Synthesis Panel on HRT.
by: Grant, C, et al.
Published: (1999)

Frequent homologous recombination deficiency in high-grade endometrial carcinomas
by: Jonge, D, et al.
Published: (2018)

Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.
by: Sivridis, E, et al.
Published: (2002)

Long-term effects of hormone replacement therapy - Reply
by: Beral, V, et al.
Published: (2003)

The dual danger of pyometra and endometrial carcinoma: a case report
by: Dayang Corieza Febriany, et al.
Published: (2024)

A meta-analysis of hormone replacement therapy for fracture prevention.
by: Altman, D
Published: (2001)

Breast cancer and hormone-replacement therapy: the Million Women Study.
by: Bliss, J, et al.
Published: (2003)

Ovarian cancer and hormone replacement therapy in the Million Women Study.
by: Beral, V, et al.
Published: (2007)

Relationship between postmenopausal hormone replacement therapy and ovarian cancer.
by: Bosetti, C, et al.
Published: (2001)

Relationship between postmenopausal hormone replacement therapy and ovarian cancer
by: Bosetti, C, et al.
Published: (2001)

Anti-Mullerian hormone and endometrial cancer: a multi-cohort study
by: Fortner, RT, et al.
Published: (2017)

Hormone replacement therapy for secondary prevention of coronary heart disease.
by: Banks, E, et al.
Published: (1999)

Breast cancer and hormone-replacement therapy in the Million Women Study.
by: Beral, V
Published: (2003)

Hormone replacement therapy for secondary prevention of coronary heart disease
by: Banks, E, et al.
Published: (1999)

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
by: Drake, WM, et al.
Published: (1998)

Synchronous endometrial and ovarian carcinoma (SEOC); case series and literature review
by: Lin, Shahzarul Fazril, et al.
Published: (2021)

The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome.
by: Elsheikh, M, et al.
Published: (2000)

Breast cancer and hormone-replacement therapy: the Million Women Study - Reply
by: Beral, V, et al.
Published: (2003)

Increasing incidence of endometrial carcinoma in a high‐risk New Zealand community
by: Bigby, SM, et al.
Published: (2020)

Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE).
by: Arden, N, et al.
Published: (1994)

Preoperative serum CA 125 is associated with myometrial and cervical invasion in endometrial carcinoma
by: Abu Bakar, Nur Aini, et al.
Published: (2020)

Preoperative serum CA 125 is associated with myometrial and cervical invasion in endometrial carcinoma
by: Abu Bakar, Nur Aini, et al.
Published: (2020)

Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect.
by: Banks, E, et al.
Published: (2006)

The immunohistochemistry signature of mismatch repair (MMR) proteins in a multiethnic Asian cohort with endometrial carcinoma
by: Woo, Y.L., et al.
Published: (2014)

Nucleoplasmic reticulum formation in human endometrial cells is steroid hormone responsive and recruits nascent components
by: Pytowski, L, et al.
Published: (2019)